Erythromycin N-Oxide Impurity

Product Description
CAT No.
ALN-E006034
CAS No.
NA
Mol. F.
C37H65NO15
Mol. Wt.
763.9
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (3R,4S,6R)-2-(((4R,4a’S,5S,6S,7’R,8’S,9’R,10’R,12’R,14’R,15’R,16’S,16a’S)-7′-ethyl-5,8′,9′,14′-tetrahydroxy-4-methoxy-4,6,8′,10′,12′,14′,16′-heptamethyl-5′,11′-dioxohexadecahydro-4’H,5’H-spiro[pyran-2,2′-[1,3]dioxino[5,4-c][1]oxacyclotetradecin]-15′-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide
Technical Data
Reference
Isolation and identification of a novel erythromycin-degrading fungus, Curvularia sp. RJJ-5, and its degradation pathway
By Ren, Jianjun; Deng, Liujie; Niu, Dongze; Wang, Zhenzhu; Fan, Bo; Taoli, Huhe; Li, Zhijie; Zhang, Jin; Li, ChunyunFrom FEMS Microbiology Letters (2021), 368(1), fnaa215.
Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets
By Jeelani, Salika; Soukhova, Nadejda – From Journal of Pharmaceutical and Biomedical Analysis (2021), 195, 113858
Degradation and mineralization of erythromycin by heterogeneous photocatalysis using SnO2-doped TiO2 structured catalysts: Activity and stability
By Albornoz, L. L.; da Silva, S. W.; Bortolozzi, J. P.; Banus, E. D.; Brussino, P.; Ulla, M. A.; Bernardes, A. M. – From Chemosphere (2021), 268, 128858
RFQ